Choroidal Neovascularization - 17 Studies Found Completed : Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial : Choroidal Neovascularization : 2006-08-09 : Drug: Ranibizumab 0.3 mg/0.05 Completed : Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized Regimen : Choroidal Neovascularisation : 2009-12-21 : Drug: ranibizumab 0.5mg Recruiting : TTT Versus PDT for Treatment of Choroidal Neovascularization in Age-Related Macular Degeneration : Choroidal Neovascularization : 2005-11-29 : Procedure: Photodynamic therapy versus Transpupillary thermotherapy Completed : Bevacizumab Intravitreal for Myopic Choroidal Neovascularization : Myopic Choroidal Neovascularization : 2008-11-24 : Drug: Injection Intravitreal injection of 1.25 mg bevacizumab Withdrawn : Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration : Choroidal Neovascularization : 2006-11-22 : Drug: Imatinib Mesylate /Ranibizumab Completed : Assess the Efficacy/Safety of Intravitreal Ranibizumab in Patients With Vision Loss Due to Choroidal Neovascularization. : Choroidal Neovascularization (CNV) : 2013-04-23 : Drug: Ranibizumab Ranibizumab Completed : Comparative Study With Photodynamic Therapy And Triamcinolone Versus Photodynamic Therapy, Triamcinolone And Ranibizumab In Patients With Subfoveal Choroidal Neovascularization : Subfoveal Choroidal Neovascularization : 2006-12-01 : Drug: intravitreal injection of ranibizumab Completed : Efficacy and Safety of Ranibizumab 0.5 vs Veteporfin PDT in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia : Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia : 2013-08-12 : Drug: Ranibizumab 0.5mg 0.5 mg Completed : Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration. : Choroidal Neovascularization : 2006-11-01 : Drug: ranibizumab 0.5mg intravitreal injection Completed : Safety and Efficacy Study of Combretastatin A4 Phosphate to Treat Patients With Choroidal Neovascularization Secondary to Pathologic Myopia : Choroidal Neovascularization Myopia, Degenerative : 2011-08-22 : Drug: Combretastatin A-4 Phosphate Combretastatin A-4 Phosphate is administered on Day 0 and Day 7 (+/- Next >>>
